LUMENIS smart532 - A.3.7. Ophthalmology Warnings; A.4. Treatment Parameters in Ophthalmology

Smart532
™
Clinical Guide
UM-1151440EN, Rev. C, May 2016 A-9
● Only appropriate tissue targets should be subject to photocoagulation.
● Attention should be paid to avoid treating major retinal vessels, as
vitreous hemorrhage and serious visual loss could occur.
● The optic nerve head should not be coagulated, as severe and
permanent visual loss could occur.
● Inadvertent macular photocoagulation, especially close to the fovea
(within 300-500µm), can cause severe and permanent visual loss.
● Excessively high power settings should not be used, as they can cause
damage to tissues adjacent to the target of interest.
Ophthalmic problems are successfully treated with laser photocoagulation.
Treatment parameters such a power, duration of the pulse and spot size
depend on a variety of factors including the type of tissue to be treated, the
intensity of the lesion desired, and the individual pigmentation of tissue
targets.
Smart532 comes with two types of waveforms: Continuous waveform
(CW) and SmartPulse.
A.3.7. Ophthalmology
Warnings
A.4. Treatment
Parameters in
Ophthalmology